Using export controls to reduce biorisk

Abstract

This article discusses how the Bureau of Industry and Security, a division of the U.S. Department of Commerce, may significantly reduce the risk associated with biotechnology. It can do this by imposing export controls and restricting the publication of information that could lead to the development of dangerous pathogens. However, there are some limitations on the use of export controls, such as the preference for multilateral action, inter-agency involvement, and the exception for fundamental research. Additionally, the constitutionality of export controls may be challenged on the grounds of freedom of speech and the First Amendment. – AI-generated abstract.